Breaking News Instant updates and real-time market news.

AKTX

Akari Therapeutics

$6.03

0.3 (5.24%)

07:09
10/11/17
10/11
07:09
10/11/17
07:09

Akari Therapeutics completes enrollment in COBALT Phase II PNH trial of Coversin

Akari Therapeutics announces that three additional patients have been enrolled in the ongoing Phase II COBALT clinical trial of Coversin in patients with paroxysmal nocturnal hemoglobinuria, or PNH. COBALT, the Phase II 90-day, open label single arm clinical trial, has enrolled a total of eight patients, four of whom have completed the trial and were reported on at the European Hematology Association conference in June 2017. These four patients have all moved into Akari's long-term safety study, CONSERVE. One of the initial five patients enrolled in the COBALT trial, with a suspected co-morbidity unrelated to the treatment, was withdrawn from the study on day 43. Three new patients were enrolled pursuant to an amended protocol based on a revised dosing regimen which included changing the maintenance phase from a single dose of 30mg every 24 hours to a single dose of 45mg every 24 hours. The three newly enrolled patients on the revised dosing regimen have now completed approximately 8, 3 and 2 weeks, respectively. The primary endpoint in this clinical trial is reduction in serum LDH, or lactate dehydrogenase; an indication of hemolysis, to less than or equal to 1.8 times the ULN, or upper limit of normal, for the investigator's reference laboratory or 500 I U/L, whichever is the lower from day 1 to day 28. The first of the three patients had a LDH value of 1.5 times the ULN at day 28. The other two patients have not yet reached the primary endpoint measurement date. To date, there have been no drug-related serious adverse events. The data reported is taken from the current electronic case report forms. Akari plans to provide an update on all PNH patients currently enrolled at the American Society of Hematology Annual Meeting to be held December 9-12, 2017. Akari plans to advance Coversin towards Phase III clinical trials beginning with CAPSTONE in Q1 2018, a Phase III clinical trial of Coversin in naive PNH patients.

AKTX Akari Therapeutics
$6.03

0.3 (5.24%)

09/22/17
WBLR
09/22/17
UPGRADE
WBLR
Outperform
Akari Therapeutics upgraded to Outperform from Market Perform at William Blair
William Blair analyst Tim Lugo upgraded Akari Therapeutics to Outperform saying coversin is progressing towards Phase III clinical studies in paroxysmal nocturnal hemoglobinuria with an achievable endpoint.
06/27/17
ADAM
06/27/17
NO CHANGE
Target $15
ADAM
Buy
Akari Therapeutics price target lowered to $15 from $33 at Canaccord
Canaccord analyst Arinda Lee lowered her price target on Akari Therapeutics to $15 from $33 following its Coversin data presentation at the EHA meeting. Lee said Coversin's efficacy is competitive, as the data indicated meaningful benefit in PNH without generating neutralizing antibodies or serious adverse events, but its pushed out timelines for launch and the lowered probability of success due to aggressive competition caused her to lower her targets. Lee reiterated her Buy rating on Akari Therapeutics shares.
05/31/17
05/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Donaldson (DCI) upgraded to Buy from Hold at Jefferies with analyst Laurence Alexander saying he sees "increasing evidence" the company's end-markets are exiting the multi-year trough and believes operating leverage should translate into above-average compound growth over the next few years. He recommends building positions in the stock during the second half of 2017. 2. VMware (VMW) upgraded to Outperform from Neutral at Baird with analyst Jason Noland citing the company's strategic shift to partner with firms rather than compete with the public cloud. 3. Akari Therapeutics (AKTX) upgraded to Neutral from Sell at Chardan. 4. Vale (VALE) upgraded to Buy from Hold at HSBC with analyst Jonathan Brandt saying the recent decline in iron ore prices has mitigated risk, and the focus should now shift to the company's "strong" free cash flow generation and 6% dividend yield. 5. Potbelly (PBPB) upgraded to Buy from Hold at Maxim with analyst Stephen Anderson citing news that Chief Executive Officer Aylwin Lewis is resigning, as he believes new management could reinvigorate performance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/31/17
CHDN
05/31/17
UPGRADE
CHDN
Neutral
Akari Therapeutics upgraded to Neutral from Sell at Chardan

TODAY'S FREE FLY STORIES

TWX

Time Warner

$94.70

0.33 (0.35%)

, CMCSA

Comcast

$39.50

0.7 (1.80%)

18:33
02/25/18
02/25
18:33
02/25/18
18:33
Hot Stocks
Box Office Battle: 'Black Panther' stays at number 1 with record $108M »

Disney (DIS) and Marvel…

TWX

Time Warner

$94.70

0.33 (0.35%)

CMCSA

Comcast

$39.50

0.7 (1.80%)

CMCSK

Comcast

SNE

Sony

$50.23

0.38 (0.76%)

FOX

21st Century Fox

$37.62

0.89 (2.42%)

FOXA

21st Century Fox

$38.01

0.85 (2.29%)

LGF.A

Lionsgate

$28.44

0.47 (1.68%)

DIS

Disney

$107.25

2.01 (1.91%)

VIAB

Viacom

$33.74

0.81 (2.46%)

VIA

Viacom

$39.00

0.85 (2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 20

    Mar

  • 23

    Apr

S

Sprint

$5.30

0.07 (1.34%)

, SNCR

Synchronoss

$9.44

0.57 (6.43%)

18:22
02/25/18
02/25
18:22
02/25/18
18:22
Hot Stocks
Sprint selects Synchronoss to lead digital transformation »

Synchronoss Technologies…

S

Sprint

$5.30

0.07 (1.34%)

SNCR

Synchronoss

$9.44

0.57 (6.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

DDAIF

Daimler AG

$88.06

1.81 (2.10%)

18:04
02/25/18
02/25
18:04
02/25/18
18:04
Periodicals
Daimler, BAIC to invest $2B in Chinese factory, Reuters reports »

Daimler and BAIC are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

BA

Boeing

$356.66

0.74 (0.21%)

, ERJ

Embraer

$27.83

0.43 (1.57%)

18:00
02/25/18
02/25
18:00
02/25/18
18:00
Periodicals
Boeing to have 51% stake in venture with Embraer, Reuters reports »

Boeing (BA) will have a…

BA

Boeing

$356.66

0.74 (0.21%)

ERJ

Embraer

$27.83

0.43 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

SSNLF

Samsung

17:57
02/25/18
02/25
17:57
02/25/18
17:57
Periodicals
New Samsung Galaxy S9 focusing on social media, Reuters reports »

Samsung has unveiled its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$14.49

-0.01 (-0.07%)

17:54
02/25/18
02/25
17:54
02/25/18
17:54
Periodicals
General Electric to restate earnings for 2016/2017, Reuters reports »

General Electric said in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$77.53

1.67 (2.20%)

17:49
02/25/18
02/25
17:49
02/25/18
17:49
Periodicals
Exxon Mobil shuts PNG gas conditioning plant amid earthquake, Reuters reports »

Exxon Mobil shut the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$63.32

1.14 (1.83%)

17:49
02/25/18
02/25
17:49
02/25/18
17:49
Hot Stocks
Qualcomm Network simulation shows significant 5G user experience gains »

Qualcomm Technologies, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

AYX

Alteryx

$33.38

-0.37 (-1.10%)

17:45
02/25/18
02/25
17:45
02/25/18
17:45
Hot Stocks
Alteryx acquires partner in Australia »

Alteryx has completed the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$94.06

2.33 (2.54%)

17:43
02/25/18
02/25
17:43
02/25/18
17:43
Hot Stocks
Packerland, Microsoft to deliver broadband internet to rural communities »

Microsoft President Brad…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 13

    Mar

  • 14

    Mar

DLB

Dolby

$62.26

0.4 (0.65%)

, SSNLF

Samsung

17:42
02/25/18
02/25
17:42
02/25/18
17:42
Hot Stocks
Dolby brings Dolby Atmos Immersive Sound on Samsung mobile devices »

Dolby Laboratories (DLB)…

DLB

Dolby

$62.26

0.4 (0.65%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

QCOM

Qualcomm

$63.32

1.14 (1.83%)

, SSNLF

Samsung

17:38
02/25/18
02/25
17:38
02/25/18
17:38
Hot Stocks
Qualcomm Snapdragon powers advanced connectivity on Samsung Galaxy S9, S9+ »

Qualcomm Technologies, a…

QCOM

Qualcomm

$63.32

1.14 (1.83%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

USM

U.S. Cellular

$36.41

3.65 (11.14%)

, SSNLF

Samsung

17:34
02/25/18
02/25
17:34
02/25/18
17:34
Hot Stocks
U.S. Cellular offers up to $350 off Samsung Galaxy S9, S9+ »

New and current device…

USM

U.S. Cellular

$36.41

3.65 (11.14%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

ICL

ICL

$4.43

0.08 (1.84%)

17:31
02/25/18
02/25
17:31
02/25/18
17:31
Hot Stocks
ICL board approves appointment of Raviv Zoller as new CEO »

ICL's Board approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LJPC

La Jolla

$32.15

-0.46 (-1.41%)

17:28
02/25/18
02/25
17:28
02/25/18
17:28
Hot Stocks
Giapreza significantly improved survival of patients with High APACHE II scores »

La Jolla Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

NOK

Nokia

$5.80

0.09 (1.58%)

, COMM

CommScope

$38.73

0.48 (1.25%)

17:24
02/25/18
02/25
17:24
02/25/18
17:24
Hot Stocks
CommScope collaborates with Nokia on MIMO integrated antenna »

CommScope (COMM) has…

NOK

Nokia

$5.80

0.09 (1.58%)

COMM

CommScope

$38.73

0.48 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOK

Nokia

$5.80

0.09 (1.58%)

17:22
02/25/18
02/25
17:22
02/25/18
17:22
Hot Stocks
Nokia to acquire software company Unium »

Nokia announced plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHL

China Mobile

$47.89

0.16 (0.34%)

, NOK

Nokia

$5.80

0.09 (1.58%)

17:19
02/25/18
02/25
17:19
02/25/18
17:19
Hot Stocks
Nokia, China Mobile to explore use of 5G to drive new business opportunities »

Nokia (NOK) and China…

CHL

China Mobile

$47.89

0.16 (0.34%)

NOK

Nokia

$5.80

0.09 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$28.96

0.6 (2.12%)

, NOK

Nokia

$5.80

0.09 (1.58%)

17:17
02/25/18
02/25
17:17
02/25/18
17:17
Hot Stocks
Nokia deploying 5G for Vodafone Italy's 5G trial in Milan »

Nokia (NOK) and Vodafone…

VOD

Vodafone

$28.96

0.6 (2.12%)

NOK

Nokia

$5.80

0.09 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

NOK

Nokia

$5.80

0.09 (1.58%)

, FB

Facebook

$183.29

4.3 (2.40%)

17:15
02/25/18
02/25
17:15
02/25/18
17:15
Hot Stocks
Nokia, Facebook working to expand ecosystem for Fixed Wireless Access over 60GHz »

Nokia (NOK) and Facebook…

NOK

Nokia

$5.80

0.09 (1.58%)

FB

Facebook

$183.29

4.3 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

RHT

Red Hat

$146.62

1.96 (1.35%)

, INTC

Intel

$47.73

1.93 (4.21%)

17:12
02/25/18
02/25
17:12
02/25/18
17:12
Hot Stocks
Cisco to form multi-vendor ecosystem to accelerate Open vRan solutions adoption »

Cisco (CSCO) announces…

RHT

Red Hat

$146.62

1.96 (1.35%)

INTC

Intel

$47.73

1.93 (4.21%)

CSCO

Cisco

$44.00

1.06 (2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 06

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 28

    Mar

  • 29

    Mar

  • 29

    Mar

  • 19

    Apr

  • 23

    Apr

DK

Delek US

$34.26

0.29 (0.85%)

17:04
02/25/18
02/25
17:04
02/25/18
17:04
Conference/Events
Delek US management to meet with Morgan Stanley »

Group breakfast meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CSCO

Cisco

$44.00

1.06 (2.47%)

17:04
02/25/18
02/25
17:04
02/25/18
17:04
Hot Stocks
Cisco, Airtel team to improve mobile user experience »

Bharti Airtel,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 19

    Apr

  • 23

    Apr

CSCO

Cisco

$44.00

1.06 (2.47%)

17:02
02/25/18
02/25
17:02
02/25/18
17:02
Hot Stocks
Cisco, TIM join forces to increase IT security of Italian companies »

Starting from March, TIM,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 19

    Apr

  • 23

    Apr

CSCO

Cisco

$44.00

1.06 (2.47%)

17:00
02/25/18
02/25
17:00
02/25/18
17:00
Hot Stocks
Cisco launches new '5G Now' portfolio »

Cisco announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 19

    Apr

  • 23

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.